WhaTech As the world's major heparin API producer and exporter, China boasts enormous raw materials, which provides a strong support for the production of China's hep...
WhaTech In terms of the proposed/ongoing projects, however, it is projected that the heparin API in China will achieve an additional capacity of more than 20 trillion units by 2015, when China's total capacity will exceed 30 trillion units, accounting for ...
FiercePharma Manufacturing After tainted Chinese heparin in 2008 led to dozens of deaths of dialysis patients in the U.S., global regulators started preaching loud and clear on the need for heparin makers to be able to track back sources to ensure they were safe. German meat ...
In-PharmaTechnologist.com Heparin production may be moving back to Europe according to the EFCG, which cited the opening of Pharma Action's processing plant as an indication that API buyers value quality and compliance throughout the supply chain. and more »
Newswise (press release) Newswise — Hamilton, ON (Nov. 18, 2014) – McMaster University researchers have found new evidence that suggests patients with a history of adver...
MedPage Today Low-molecular weight heparin might be more cost-effective than unfractionated heparin for venous thromboembolism (VTE) prevention in critical illness, ...
Scientific American Clots are clumps of blood cells, platelets and proteins, and so it seemed logical to think that diluting, or thinning, the blood with heparin would...
The Biological SCENE A research team led by Jayachandran N. Kizhakkedathu of the University of British Columbia recently designed a reversal agent for heparin (Sci. Tr...
Ubyssey Online Kizhakkedathu said that one to three percent of the global population uses heparin . It is not only used for the regular treatment of cardiovascular disease such as venous or arterial thromboembolism but also in most surgeries and all dialysis procedures.
MedPage Today Aripazine is a synthetic small molecule (D-arginine compound) that has broad activity against various old ( heparin , low-molecular-weight heparin ) and new oral anticoagulants (dabigatran [Pradaxa], rivaroxaban [Xarelto], apixaban [Eliquis], and edoxaban ...
